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ABSTRACT
The ATRX gene encodes a chromatin remodel-
ing protein that has two important domains, a
helicase/ATPase domain and a domain composed
of two zinc fingers called the ADD domain. The
ADD domain binds to histone tails and has been
proposed to mediate their binding to chromatin.
The putative ATRX homolog in Drosophila (XNP/
dATRX) has a conserved helicase/ATPase domain
but lacks the ADD domain. In this study, we
propose that XNP/dATRX interacts with other
proteins with chromatin-binding domains to recog-
nize specific regions of chromatin to regulate gene
expression. We report a novel functional interaction
between XNP/dATRX and the cell proliferation
factor DREF in the expression of pannier (pnr).
DREF binds to DNA-replication elements (DRE)a t
the pnr promoter to modulate pnr expression.
XNP/dATRX interacts with DREF, and the contact
between the two factors occurs at the DRE sites,
resulting in transcriptional repression of pnr. The
occupancy of XNP/dATRX at the DRE, depends
on DNA binding of DREF at this site. Interestingly,
XNP/dATRX regulates some, but not all of the genes
modulated by DREF, suggesting a promoter-
specific role of XNP/dATRX in gene regulation.
This work establishes that XNP/dATRX directly
contacts the transcriptional activator DREF in the
chromatin to regulate gene expression.
The human Alpha-Thalassemia and mental Retardation
X-linked syndrome (hATRX) gene encodes a chromatin
remodeling protein that contains several conserved
motifs. The ATRX protein has a helicase/ATPase
domain of the SWI/SNF family at its carboxyl terminus,
and this domain is characteristic of the catalytic subunits
of chromatin remodeling complexes (1). At its amino
terminus, the ATRX protein has a domain composed of
a Plant Homeo Domain (PHD) and a GATA-like
zinc-ﬁnger motif, known as the ATRX-DNMT3A-
DNMT3L (ADD) domain because this conﬁguration
of Zinc ﬁngers has been found in the DNA-methyl-
transferases DNMT3A and DNMT3L (2). The ADD
domain of the DNMT3A and DNMT3L proteins has
been shown to bind histone tails (3). This interaction has
been proposed to mediate the recruitment of these
proteins to chromatin (4). The ADD domain of hATRX
is very similar to the one present in the DNMTs and
recently has been reported to bind H3 when its K4, and
K9 residues are methylated (5–7).
Mutations in hATRX are associated with several syn-
dromes linked to the X chromosome. For this reason,
most of the patients affected are males. Patients with
mutations in hATRX have developmental defects in
the urogenital system, suffer severe dysfunctions in the
central nervous system, suffer from a-thalassemia, have
impaired motor abilities, and display a characteristic
facial dysmorphism. About 50% of the mutations
detected in patients afﬂicted with ATRX syndrome are
located in the ADD region, and  30% are in the SNF2
domain (1).
Some of the phenotypes observed in patients carrying
ATRX mutations may be due to the role of ATRX in the
regulation of transcription. As a result, different molecu-
lar studies have focused on elucidating the role played by
ATRX in transcription (8,9). A recent genome-wide
analysis of human and mouse cells demonstrates that
ATRX can bind G-rich tandem repeat sequences.
Importantly, genes associated with these tandem repeat
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Furthermore, the same study shows that ATRX can
directly bind to G-rich sequences that may form G
quadruplex structures (10). In addition, mammalian
ATRX is capable of interacting with other cellular
factors including Heterochromatin Protein 1 (HP1),
Methyl-CpG-binding protein (MeCP2), cohesin, CCCTC
-binding factor (CTCF) and the Death Associated
Protein-6 (DAXX) presumably acting together as a H3.3
chaperone (11–15). The interaction of ATRX with CTCF
and MeCP2 results in the repression of imprinted gene
expression in the postnatal mouse (15). In addition,
evidence suggests that in mice, the PAR genes are posi-
tively regulated by ATRX (16). In fact, expression of
the a-globin genes is affected when ATRX is mutated,
and this effect is determined by the number of the
tandem G-rich repeats sequences upstream of this gene,
suggesting that the ATRX mechanisms that inﬂuence gene
expression are complex (10). Indeed, it is not clear if all the
cases involve a direct interaction with chromatin or if
this activity is mediated by an interaction with other
undescribed factors. Therefore, the mechanism by which
ATRX regulates gene expression is currently unknown.
In Drosophila, XNP/ATRX is present as two isoforms
(dATRXS and dATRXL) that are derived from the use of
two alternative translational start codons (17). While some
reports suggest that XNP/dATRXL interacts with HP1 in
heterochromatic regions, including the chromocenter,
other studies show evidence that dATRXL can also be
located in euchromatin (18,19). The dATRXS isoform
has also been shown to be distributed in different
regions across polytene chromosomes (19). In Drosophila,
XNP/dATRX mutants act as suppressors of position
effect variegation (18,19). Therefore, it is likely that
XNP/dATRX is a chromatin-associated protein in
the ﬂy. However, although both XNP/dATRX isoforms
conserve the ATPase/helicase domain, they lack the
human ADD domain, suggesting that these proteins
participate in the control of gene expression through
protein–protein interactions with other cell factors that
may have DNA or chromatin binding domains.
To test this hypothesis and to ﬁnd putative XNP/
dATRX partners, we used XNP/dATRX as a bait to
screen an embryonic cDNA library through a yeast two-
hybrid analysis, We identiﬁed, among several factors,
that the transcription factor DREF interacts in vitro and
in vivo with dATRX. DREF recognizes the consensus
DNA element 50-TATCGATA-3, which is highly preva-
lent in core promoters and is known as the DNA
replication-related element (DRE) (20). In Drosophila,
DREF regulates the expression of several genes that are
required during the S phase of the cell cycle, such as
PCNA, E2F and DNApol- (22–24). Physically, DREF
interacts with factors involved in chromatin structure
and dynamics (25,26), and the wide spectrum of genes
regulated by DREF suggests that this transcription
factor acts in conjunction with a diverse array of
transcriptional regulators.
The interaction between XNP/dATRX and DREF
results in the regulation of pannier (pnr) gene transcrip-
tion. Mechanistically, we found that DREF binds to DRE
elements present in the pnr promoter, where it works
to maintain correct levels of pnr gene expression. The
interaction of XNP/dATRX with DREF results in the
repression of pnr transcription. These results suggest a
dynamic interaction between XNP/dATRX and DREF
to control the expression of a factor that is required for
various biological processes during the development of
Drosophila.
MATERIALS AND METHODS
Fly stocks
The wild-type ﬂies used in this study were Oregon
R(OreR), and ﬂy stocks were maintained at 25 C with
standard food. All stocks were obtained from the
Bloomington, Indiana stock center. RNAi transgenic
ﬂies for DREF and XNP/dATRX on chromosome 3
were obtained from the Vienna Drosophila RNAi center
(VDRC). Df(3R)Exel6202 is a deﬁciency that does not
have XNP/dATRX (deletes polytene chromosome bands
96D1-96E2), In this work, we called this deﬁciency
Df(ATRX).
Establishment of UAS-RNAi transgenic ﬂies
The pSymp-UAST plasmid was kindly provided by Dr E.
Giordano and used to make transgenic ﬂies for expression
of an inducible RNAi against XNP/dATRX. A fragment
containing XNP/dATRX bases 3765–4087 was cloned
into the pSymp-UAST. The resulting transgene is called
UAS-dATRXi. Transgenic ﬂies were made by Genetic
Services Inc. Transgenic ﬂies carrying a transgene
used for the expression of an inducible RNAi for DREF
(UAS-DREFi) were obtained from the Vienna Drosophila
RNAi Center (VDRC).
Genetic crosses
All stocks were crossed ﬁrst with w
1118 or with OreR
ﬂies in order to homogenize the genetic background.
The transgene called UAS-dATRX is P{Mae-
UAS.6.11}XNP
UY3132 (27). It carries an UAS sequence
inserted at the 50-UTR of the XNP/dATRX gene.
Transgenic RNAi lines carrying the transgenes in chromo-
somes 2 or 3 were established and balanced with CyO for
chromosome 2 and with TM2, Ubx, TM3, Ser or TM6B,
Tb balancers for chromosome 3. The drivers used to
express the UAS-XNP/dATRX, UAS-XNPi or UAS-
DREFi transgenes were Act5C-Gal4, 455.2-Gal4 (28) or
pnr-Gal4. These drivers direct transgene expression
ectopically, in the scutellum, or in the pnr domains,
respectively.
Antibodies
Antibodies were raised in rats or rabbits against XNP/
dATRX using the peptide p4:CVVRLKRVSLPKTK
PAQ which recognizes XNP/dATRXL. The polyclonal
rabbit anti-DREF antibody has been previously reported
(29). Polyclonal rabbit anti-Pnr antibody was kindly
provided by Dr Gine ´ s Morata.
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Salivary glands from third instar larvae were ﬁxed in
solution I (PBS, 3.7% paraformaldehyde and 1% Triton
X-100) and then in solution II (3.7% paraformaldehyde,
50% acetic acid). The chromosomes were spread on poly-
L-Lysine coated microscope slides. Anti-DREF antibody
was used at 1:200 and anti-dATRX antibody at 1:100.
Secondary antibodies ALEXA ﬂuor 488 or 568
(Invitrogen) were used at 1:500. Images were taken on a
confocal laser scanning microscope (Zeiss LSM 510
META).
Electrophoretic mobility shift assays
Electrophoretic mobility shift assays (EMSAs) were
performed as previously described (30). Nuclear extracts
were obtained from adult ﬂies or embryos using the
protocol described in (31). Oligonucleotides sequences
are indicated in Figure 4. Competitions were performed
with a 100-fold molar excess of unlabeled oligonucleo-
tides, and 100000cpm of g-
32P ATP-labeled paired oligo-
nucleotides were used per lane. EMSA-WB was performed
as described in (32).
Pull-down assays
Pull-down assays were performed using the TNT-Quick-
Coupled Transcription/Translation System (Promega)
according to the manufacturer’s instructions. A clone
from the Drosophila Genomics Resource Center contain-
ing full length DREF cDNA was used for the in vitro
translation of DREF.
Yeast two-hybrid screen
Yeast two hybrid assays were performed using the BD
Matchmaker library construction and screening kit
(Biosciences-Clontech) according to manufacturer’s
instructions. The cDNA library was made from 0 to 12h
embryos. The assay was performed using the amino-
terminus (amino acids 1–221) or the carboxy-terminus
(amino acids 1147–1308) of XNP/dATRX as bait.
Screening for positive interactions was performed by
co-transformation and/or yeast mating. Positive inter-
actions were analyzed by growth in QDO medium and
X-a-galactosidase or b-galactosidase assays.
Co-immunoprecipitation assays
Embryo or adult ﬂy nuclear extracts were prepared as
described in (33). This protocol allows us to maintain
the ‘transcriptionally active’ nuclear fraction free of
membranes and DNA. Co-IP was performed as described
in (34).
qRT–PCR assays
RNA was obtained using the Trizol method or the
protocol reported in (35) from 0 to 12h embryos or
adult ﬂies expressing the RNAi against XNP/dATRX or
from overexpressing dATRX. Equal amounts of RNA
(1mg) were used for ﬁrst strand synthesis reactions.
qRT–PCR reactions were performed using the light
cycler DNA master SYBR green 1. All of the
oligonucleotide sequences used in this study are available
upon request. Relative quantiﬁcation was performed by
the ct-method. All reactions were performed in
triplicate.
ChIP, ChIP–western and Re-ChIP assays in embryos
The 0- to 14-h-old embryos were collected, dechorionated
and ﬁxed (36). The ﬁxation reaction was stopped by
adding glycine (125mM). Embryos were washed and
resuspended in lysis buffer, and sonication was performed
until the size of chromatin reached between 200 and
800bp. Pre-clearing, antibody incubations, immunopre-
cipitation and phenol:chlorophorm extractions were
performed as described in (30). For the ‘mock’ condition,
a pre-immune sera against XNP/dATRX or an anti-GFP
antibody were used. The following oligonucleotides were
used for pnr-: FWD 50-CGGCCTGCTAAGTGAGTG
TGA-30, REV 50-CCGGTTGGATGTGCGCTGAG-30
and for pnr-a: FWD 50-CCTTCAGTACCCACAATATC
GCC-30, REV 50-GAACTAAGATTTAAACCACC-30.
qPCRs were then performed using the light cycler DNA
master SYBR green 1 run in a Lyght cycler 1.5 (ROCHE),
and the relative quantiﬁcation was performed as follows.
The percentage of INPUT was calculated using the
formula:
%Input ¼ 2ð Ct ½normalizedCh IP ÞCt½normalized ChIP 
¼ð Ct ½ChIP  ð Ct ½Input  Log2 ðinput dilution factorÞ,
where input dilution factor = (fraction of the input
chromatin saved)
 1 as described in Champion-ChIP TM
qPCR Primers. Quantitative real-time PCR analysis of
chromatin, SA. Biosciences 2008. All the assays were
performed at least three independent times unless stated
otherwise. All of the data were obtained from at least
three independent experiments (37). For the ChIP–
western experiments, the ChIP protocol was followed
through the ﬁnal wash of the agarose beads and protein
complexes with TE buffer. The denatured complexes were
migrated in an 8% polyacrylamide gel and transferred
to a nitrocellulose membrane. WB was conducted using
the anti-XNP/dATRX antibodies (described above) or the
anti-DREF antibody.
For the Re-ChIP experiments, the ChIP protocol was
followed through the last wash of the agarose beads and
protein complexes with TE buffer, after which the agarose
beads were resuspended in 100ml of 10mM DTT
and incubated at 37 C for 1h to dissociate the protein
complexes from the beads. The supernatant was
removed and diluted in IP buffer, and immunopre-
cipitation was performed using the second antibody. The
standard ChIP protocol was followed to obtain the DNA
that was then analyzed by qPCR as described above.
RESULTS
XNP/dATRX physically interacts with DREF
To ﬁnd putative XNP/dATRX interacting proteins, we
performed a yeast two-hybrid screen. To achieve this, we
constructed a cDNA library from 0 to 12h embryos in
1462 Nucleic Acids Research, 2012,Vol.40, No. 4which cDNAs were linked to the sequence encoding the
GAL4 activation domain. Meanwhile, the N-terminal
(amino acids 1–221) and C-terminal (amino acids 1147–
1308) regions of XNP/dATRX were used as baits.
The SNF2/helicase–ATPase domain was not used in this
screen because it is also conserved in other factors. Several
bona ﬁde candidates were identiﬁed, as well as some
encoded proteins involved in gene transcription and chro-
matin dynamics (Supplementary Table S1). Among these
candidates, we decided to analyze DREF (Supplementary
Figure S1) in more detail because it is a transcription
factor that participates in several cellular functions and
has been shown to interact with proteins involved in
chromatin dynamics, such as Mi-2 (29,38).
In the yeast two-hybrid screen, the activation domain
of DREF called the CR3 was found to interact with
the N-terminal portion of XNP/dATRX (Figure 1).
To conﬁrm this interaction, we performed in vitro GST-
pull-down and co-immunoprecipitation (CoIP) experi-
ments. In the pull-down experiments, a full length
DREF or CR3 domain sequences were in vitro transcribed
and translated to produce an S
35-labeled DREF protein,
or the S
35-labeled CR3 domain, to monitor their binding
with a XNP/dATRX-N-terminal-GST fusion protein
(Figure 1A). In these pull-down assays we found that
both, the S
35-labeled DREF protein and the S
35-labeled
CR3 domain bound more strongly to XNP/dATRX-
N-terminal-GST coupled to a glutathione sepharose
column than to GST alone (indicated in the corresponding
lanes as NH3-GST in Figure 1B).
To conﬁrm the yeast two-hybrid analysis and the results
of the GST pull-downs, we performed a Co-IP experiment
using protein extracts from the transcriptionally active
chromatin fraction from adult ﬂies and embryos (see
‘Material and Methods’ section) and an anti-XNP/
dATRX antibody that only recognizes the large XNP/
dATRX isoform (dATRXL). The presence of DREF
in the proteins precipitated by the dATRXL antibody
was determined using an anti-DREF antibody.
Figure 1C shows that XNP/dATRX could be efﬁciently
immunoprecipitated with the antibody and that DREF
co-immunoprecipitated with it. We also performed
a reciprocal CoIP using the DREF antibody to immu-
noprecipitate proteins from the adult ﬂies or embryo
extracts and found that XNP/dATRX also
co-immunoprecipitates (Figure 1C). Intriguingly, the
detection of DREF by western blot analysis after the
CoIP using the XNP/dATRX antibody suggests that
most of the DREF protein interacts with XNP/dATRX
because no signal can be detected in the unbound fraction.
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Figure 1. Physical interaction between XNP/dATRX and DREF. (A) Representation of the fragments assayed by pull down, the three conserved
regions of DREF are shown (gray boxes), CR3 corresponds to the region that interacts with XNP/dATRX in the two-hybrid assay. On the right
side, the 221 amino acids of XNP/dATRX used for the two-hybrid and the pull-down assays is shown. (B) Pull-down assay. For both panels: the ﬁrst
lane shows the amount of transcription/translation labeled protein (full-length DREF or the CR3 domain) used for each experiment (input), the
second lane is the experimental interaction (GST-dATRX and dDREF) and the third lane is the control interaction (GST and dDREF) for each
analyzed polypeptide. (C) CoIP of XNP/dATRX and DREF. Transcriptional active nuclear fraction from adult ﬂies or 0–24h embryos (NE); P1 is
the pre-clearing 1; P2 is pre-clearing 2; UB correspond to the unbound protein fraction; Mock is the incubation with an unrelated antibody, the
upper and middle panels correspond to an IP performed against XNP/dATRX. Upper panel was blotted with a-dATRX, middle panel with
a-dDREF and the lower panel again with a-dATRX after an IP against DREF.
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experimental conditions, the unbound DREF is unstable
and degraded during the clearing procedure. Nevertheless,
taken together, the results presented in this section
strongly suggest that dATRX and DREF interact physic-
ally in Drosophila.
XNP/dATRX behaves genetically as a repressor of
pnr function
Because pnr expression is likely regulated by XNP/
dATRX (39), we studied the role of XNP/dATRX and
DREF (see below) on gene expression. To do this, we
used as a test system the modiﬁcation of adult phenotypes
shown by pnr mutant ﬂies in conditions where the levels of
ATRX or DREF are manipulated through the expression
of transgenes carrying UAS-dATRX or sequences
encoding RNA is for XNP/dATRX (UAS-dATRXi)o r
DREF (UAS-DREFi). This allowed us to reduce the
levels of these proteins in particular domains, according
to the Gal4-driver used.
pnr encodes two isoforms, Pnr-a and Pnr-b, transcribed
from two different promoters (40). Pen ˜ a-Rangel et al. (39)
showed that overexpression of XNP/dATRX enhances the
thorax and scutellar abnormalities found in heterozygote
individuals carrying the pnr-Gal4 mutation. In pnr-Gal4,
a transposable element carrying the Gal4 gene is inserted
just upstream of the ﬁrst pnr exon transcribed from the
pnr- promoter (40). Consequently, in pnr-Gal4 individ-
uals, Gal4 expression closely mimics normal pnr- expres-
sion in wing imaginal discs and in adult ﬂies (40).
In homozygote pnr-Gal4 wing discs, the levels of pnr-
transcripts are reduced, while those of pnr- are increased
(41). pnr-Gal4 ﬂies die as homozygotes, and only 1–3%
develop into adults. pnr-Gal4 heterozygote adult ﬂies
have a very slight dorsal thoracic cleft and disorganization
of bristles, sometimes missing a few inner and post-vertical
bristles (39). For this set of experiments, we also used the
pnr
1 and pnr
VX6 alleles (40). pnr
1 presents a stop codon
at position 180 (W
180@), interrupting the ﬁrst zinc ﬁnger
found in Pnr-b, and it is considered to retain some activity
(42). pnr
VX6 is a small deﬁciency that deletes the complete
pnr locus (40). pnr
1 and pnr
VX6 are recessive lethal, and
their adult phenotypes are normal in heterozygosis.
We found that individuals expressing the transgene
UAS-dATRX in the pnr adult territory, using the
pnr-Gal4 line as a GAL4 source, showed a strong
thoracic cleft and scutellar defects (Figure 2A) similar to
the enhancement of the pnr defects found by Pen ˜ a-Rangel
et al. (39) with the overexpression of XNP/dATRX.
As pnr-Gal4 is by itself a pnr allele and a pnr GAL4
driver, interpretation of these results could be difﬁcult.
Thus, we drove the expression of the UAS-dATRX trans-
gene with two other drivers, the ectopic Act5C-Gal4 and
the 455.2-Gal4 drivers. The latter one was used to direct
the UAS-dATRX transgene expression to the scutellum in
wild-type pnr or in pnr
1 or pnr
VX6 backgrounds (Figure 2).
Importantly, these experiments validate pnr-Gal4 as a
suitable tool for these kinds of experiments because
equivalent results can be obtained with different drivers
and with different pnr alleles.
We found that ectopic expression of UAS-dATRX with
the Act5C-Gal4 driver in the presence of wild-type pnr or
with pnr
VX6 is semilethal or lethal, respectively, and
surviving adult ﬂies (when wild-type pnr is present) do
not show any morphological defects (data not shown).
With the 455.2-Gal4 driver, we found lethality that could
not be attributed to the effect of UAS-dATRX expression
(Figure 2B); however, expression of UAS-dATRX in the
scutellum enhances the scutellar defects shown by the ﬂies
of the control genotypes (ﬂies with the 455.2-Gal4 driver
and with pnr
1 or pnr
VX6 but without the UAS-dATRX
transgene). These defects are not observed when the
UAS-dATRX transgene is expressed in a wild-type pnr
background (Figure 2B).
Based on these genetic results, we hypothesized that
XNP/dATRX may act as a repressor of pnr expression.
Therefore, we evaluated whether a reduction in XNP/
dATRX levels (using RNA interference) could suppress
the phenotypes found in pnr-Gal4 ﬂies. Flies expressing
the UAS-dATRXi transgene with the Act5C-Gal4 driver
did not exhibit any visible defect, although there was
a reduction of XNP/dATRX mRNA levels (data not
shown). In contrast, the expression of UAS-dATRXi
with the pnr-Gal4 driver suppressed the lethal phenotype
of homozygous pnr-Gal4 ﬂies (Supplementary Figure S2
and Figure 2C). The suppression of lethality was greater
when two copies of the UAS-dATRXi transgene were
present (Figure 2C). Similar results were obtained with
a different UAS-dATRXi RNAi line obtained from the
Vienna Drosophila RNAi stock collection (data not
shown). In addition, pnr-Gal4/pnr
VX6 heteroallelic ﬂies
do not survive well (40); however, this is alleviated with
the expression of one copy of the UAS-dATRXi transgene
(Figure 2C). Furthermore, embryonic transcript levels of
pnr isoforms respond to XNP/dATRX levels. Through the
action of the Act5C-Gal4 driver during embryogenesis,
XNP/dATRX depletion (by UAS-dATRXi expression)
or overexpression (by UAS-dATRX expression) increases
or decreases, respectively, the transcript levels of both pnr
isoforms (Figure 2D). Thus in summary, overexpression
of XNP/dATRX causes or enhances phenotypes that can
be interpreted as a reduction of pnr function; meanwhile,
reduction of XNP/dATRX levels rescues these pheno-
types, suggesting that dATRX negatively regulates pnr
expression.
DREF binds to DRE elements in the pnr control region
In silico analyses have revealed more than 250 DRE
elements in the promoter regions of various genes,
including genes involved in DNA metabolism, transcrip-
tional regulation, protein synthesis and signal transduc-
tion mechanisms. Therefore, because DREF interacts
with XNP/dATRX, we decided to search for DRE
elements in the pnr regulatory region. The pnr locus
encodes two isoforms expressed from two different pro-
moters, named pnr- and pnr- (41). Two DNA elements
containing the DRE consensus sequence were found in the
vicinity of the pnr regulatory region: one  85bp from the
putative transcriptional start site of the b-isoform and the
other 3.9kb upstream of the putative pnr- transcription
1464 Nucleic Acids Research, 2012,Vol.40, No. 4start site (Figure 3A). We named these two elements
Dre-pnr and Dre-pnr. Next, to determine whether oligo-
nucleotides containing the putative DRE elements were
shifted by proteins in adult ﬂy nuclear extracts, we
performed an EMSA analysis. As a positive control, we
used the DNA polymerase-a DRE element (Dre-pol), a
known DREF binding site. As a non-competing element,
we used the same Dre-pol sequence with a three-base
mutation in the consensus element, as reported by Ida
et al. (21; Figure 3A). Figure 4B shows that proteins in
the nuclear extracts formed a complex with either
Dre-pnr, Dre-pnr or Dre-pol: in all three cases the
radioactive binding signal was inhibited by a 100-fold
molar excess of the Dre-pol non-radioactive oligonucleo-
tide but not by the mutated Dre-pm oligonucleotide at the
same molar excess (Figure 3B). These results suggested
that the two DRE elements present in the pnr control
region could be recognized by a nuclear factor and
that this interaction could be inhibited with the
DRE-pol oligonucleotide but not by the mutated
Dre-pm oligonucleotide. Next, we assessed whether
DREF was part of the shifted complexes. Initially, we
used the DREF antibody to identify super-shifted
complexes; however, this antibody was not able to
produce any super-shift, even with the positive control
Dre-pol oligonucleotide. After DREF antibody incuba-
tion with the nuclear extracts and with each oligonucleo-
tide, the formation of the complex was reduced, suggesting
that the DREF antibody sequestration inhibits the
putative DREF–DNA interaction (data not shown).
Therefore, to assess the presence of DREF in these
complexes, we performed an EMSA–western experiment.
Indeed, we found that the DREF antibody recognizes the
complexes bound at the Dre-pnr and Dre-pnr oligo-
nucleotides (Figure 3C). No signal was detected in a
similar western blot analysis performed with an antibody
which does not recognize DREF. To conﬁrm that DREF
binds to the Dre-pnr elements, we incubated nuclear
extracts with or without the different oligonucleotides
to allow the formation of the complexes. The presence
of DREF in the formed complexes was determined by
western blot analyses with the anti-DREF antibody in
the nuclear protein extracts separated electrophoretically
under native conditions (Figure 3D). These results show
A
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Figure 2. Modiﬁcation of pnr mutant phenotypes by XNP/dATRX dosage. (A) Enhancement of the thoracic cleft phenotype by the expression of the
UAS-dATRX transgene in the pnr-expression domain. The genotypes of each organism are indicated at the top. Note the enhancement of the thorax
cleft defect in the UAS-dATRX/pnr-Gal4 ﬂy. This result is in agreement with Pen ˜ a-Rangel et al. (39) where they used a different P-UAS construct
that overexpresses XNP/dATRX in the pnr expression domain (27). (B) Enhancement of pnr
VX6 and pnr
1 scutellar defects by the expression of
theUAS-dATRX transgene in the scutellum. Relevant genotypes are indicated. The scutellar defects consists of a reduction in the scutellum size and
deformations in the scutellar border (data not shown). No defects in the macrochaetes were observed in these ﬂies. (C) XNP/dATRX depletion
rescues the lethality of pnr mutant ﬂies. *Homozygous pnr
VX6 ﬂies die as embryos (40). Homozygous pnr-Gal4 or pnr-Gal4/pnr
VX6 adult ﬂies survive
in the presence of one or two copies of the UAS-dATRXi transgene. (D) Modiﬁcation of pnr transcript levels by XNP/dATRX. Expression of
transgenes was driven by the Act5C-Gal4 driver. Depletion of XNP/dATRX by ectopic expression of the UAS-dATRXi transgene increases the
transcript levels of the two pnr isoforms in Drosophila embryos. On the contrary, ectopic expression of XNP/dATRX by the UAS-dATRX transgene,
reduced bothpnr mRNA levels. The quantiﬁcation of the mRNA of mutant embryos was performed by RT–qPCR compared with the relative
mRNA levels of wild-type embryos of the same age. The relative expression levels are adjusted to one, which is the level of each pnr isoform
transcript in wild-type ﬂies. Data are from three different experiments.
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the Dre-pnr, Dre-pnr- and Dre-pol oligonucleotides
suggesting, as in the EMSA analysis, that DREF found
in the nuclear extracts interacts with Dre-pnra, Dre-pnr-
and Dre-pol elements. To complement these data, we
performed ChIP experiments using chromatin obtained
from 0 to14h developed embryos. DREF was detected
at the Dre-pnr elements and at the DRE-PCNA
element, which was used as a positive control, indicating
that DREF binds the Dre-pnr element in vivo
(Supplementary Figure S3). In addition, we performed
ChIP experiments with several PCR primer sets over the
pnr and pnr promoter region and found that the DREF
signals peaks at the two putative DRE elements but it is
enriched at the DRE-pnr element (Figure 3E). The detec-
tion of DREF at the DRE-pnr element was marginal
(Figure 3E and Supplementary Figure S3). However, we
cannot exclude the possibility that this element could be
recognized by DREF at other developmental stages.
We also performed a bioinformatics search for DRE
elements in the putative regulatory regions of the pnr
homologs in other Drosophila species. Assuming that pnr
also encodes two isoforms in these other species, we
found that a putative Dre-pnr element is conserved in
other Drosophila species (Supplementary Figure S4).
A putative Dre-pnr- element was found to be conserved
AB
E D C
Figure 3. DREF binds to two DRE elements in the pnr control region. (A) Localization of the two DRE (Dre-pnr and Dre-pnr) consensus
sequences near the transcription initiation site of the pnr- ( 85bp) and pnr- ( 3.9kb) transcripts. The sequence of the two Dre pnr elements, the
Dre-pol and a mutant form (DRE pm) used as positive and negative controls respectively are also shown. The insertion site of the pnr-Gal4 driver is
also indicated. (B) EMSA analysis of the DRE elements found in the pnr- and a control region. P
32-labeled double-strand oligonucleotides with the
sequences indicated in the panel A were incubated with Drosophila nuclear extracts with or without competing non-labeled oligonucleotides (100-fold
molar excess of the same and the mutant non-radioactive oligonucleotides). The arrow shows the shifted complex. (C) EMSA-western blot used to
identify the presence of DREF in the shifted complexes. In the left panel a typical EMSA is observed after the incubation of nuclear extracts with the
Dre-Pola, Dre-pnr and Dre-pnr oligonucleotides. The central panel shows a western blot using an anti-DREF antibody after the transfer of the
EMSA to a nitrocellulose membrane. The right panel shows a western blot after the transfer of the DRE-protein complexes, but using a not related
antibody as a control. (D) Native DREF is shifted in the presence of the DRE oligonucleotides. Western blots are shown after the transfer of total
nuclear proteins previously incubated with the DRE oligonucleotides and separated in a native polyacrilamide gel. Note that in the presence of the
different DRE oligonucleotides the band recognized by the DREF antibody is shifted when compared to the one without DNA indicated as ( ).
A control western blot using an unrelated antibody is also shown. (E) ChIP assays using a speciﬁc antibody against DREF to determine the
distribution DREF factor around and on the putative pnr- and pnr-DRE in chromatin derived from embryos. Graphs show results from three
independent immunoprecipitation reactions (n=3). ChIP signals quantiﬁed by means of quantitative polymerase chain reaction, are presented as
percentage of the input/percentage of the mock antibody. As it can be observed in the ﬁgure, the pnr- chromatin region shows the maximum
enrichment when the precipitation was carried out with the DREF antibody.
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suggest that DREF recognizes at least one DRE element
located upstream of the pnr- promoter.
Genetic interaction between DREF and XNP/dATRX in
pnr gene regulation
In the previous sections, we showed that DREF binds
directly to XNP/dATRX and to the DRE sites at the pnr
promoter, suggesting a possible role of DREF in the
control of pnr gene expression. Therefore, we investigated
the effect of knocking down DREF using the pnr-Gal4
driver. We used the transgenic UAS-DREFi line from
the Vienna Drosophila RNAi stock collection (43). A
reduction in the DREF protein level was detected in the
thorax of adult ﬂies expressing the UAS-DREFi RNAi
transgene (Supplementary Figure S5). Interestingly, indi-
viduals expressing the UAS-DREFi transgene with the
pnr-Gal4 driver showed a dramatic enhancement of
thoracic cleft defects (Figure 4A and Table 1). We also
noticed a reduction in macrochaete number in the pnr
expression domain, as well as the presence of thinner
bristles when compared to the ones in pnr-Gal4/+ ﬂies
without the transgene (Figure 4A and Table 1).
Depletion of DREF in ﬂies expressing the UAS-DREFi
transgene with the 455.2-Gal4 driver, causes the dis-
appearance of machrochaetes in the scutellum
(Supplementary Figure S6, middle panel). Interestingly,
when a mutant pnr allele such as pnr
1 (Supplementary
Figure S6, right panel) or pnr
VX6 (data not shown) is
A
B
Figure. 4. Suppression of the thoracic cleft induced by DREF knockdown in pnr-Gal4 heterozygous ﬂies, by depletion of XNP/dATRX.
(A) UAS-DREFi (top panel, left) or UAS-dATRXi (bottom panel, left) have a normal thorax, meanwhile ﬂies with UAS-DREFi expression in the
pnr domain driven by the pnr-Gal4 driver (middle and right top panels) show strong thoracic cleft defects. Depletion of XNP/dATRX in these ﬂies,
accomplished by the expression of the UAS-dATRXi transgene in the pnr domain, alleviates this defect (middle and right bottom panels). (B) pnr
transcript levels are inﬂuenced by DREF and XNP/dATRX dosages. pnr-a and transcript levels in the thorax of ﬂies depleted of DREF and DREF
and XNP/dATRX in the pnr expression domain (genotypes as in Figure 4A). Note that in the thorax of DREF depleted ﬂies there is a signiﬁcant
reduction of the pnr- transcript levels. These levels are recovered when DREF and XNP/dATRX are simultaneously depleted in the pnr expression
domain and partially recovered the ratio between pnr- and pnr- mRNAs. The quantiﬁcation was obtained from three independent experiments and
each cDNA was ampliﬁed three times by qRT–PCR. The Dmp8 transcript levels were used as reference control, which is not affected by the
XNP/dATRX levels.
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These results, together with the binding of DREF in the
promoter region of pnr-, suggest that DREF is a positive
regulator of pnr expression.
Because our data show that XNP/dATRX and DREF
may be antagonistic pnr transcriptional regulators, we
tested the effect of XNP/dATRX knockdown in the
UAS-DREFi/pnr-Gal4 ﬂies, expecting that the enhance-
ment of the thoracic cleft presented by DREF depleted
pnr-Gal4 ﬂies (Figure 4A, upper panel) would be sup-
pressed by the depletion of XNP/dATRX. Indeed, we
found that this was the case. Figure 4A (lower panel)
shows a reduction of the thoracic cleft defect of
UAS-DREFi/pnr-Gal4 ﬂies when the levels of XNP/
dATRX were diminished (Table 1).
We determined the levels of pnr-a and pnr- transcripts
in the thorax of these ﬂies (Figure 4B). We found that in
heterozygous pnr-Gal4 ﬂies, the pnr- transcript level
is reduced and the pnr- transcript level is increased, in
accordance with previous studies in which the transcript
levels of the different isoforms were studied (41). When
DREF is depleted in the pnr domain, pnr- transcript
levels are further diminished, supporting the positive role
of DREF in pnr- expression. On the contrary, when
XNP/dATRX is depleted, the pnr- transcript level is
increased in comparison to the level found in wild-type
ﬂies, supporting the negative role of XNP/dATRX in
pnr expression. In this latter condition, we found a
decrease in the pnr- transcript level compared to the
wild-type level probably due to indirect effects of Pnr-
on pnr- transcription (41). The differences between the
transcript levels of pnr in embryos versus the wing disc
when XNP/dATRX is depleted could be attributed
to differences in pnr regulation during development.
Interestingly, depletion of both DREF and XNP/
dATRX in the pnr-Gal4 domain recovers the ratio
between pnr- and pnr- transcript levels (Figure 4B).
These results support the idea that besides their physical
interaction, DREF and XNP/dATRX also interact
genetically and have antagonistic roles in pnr transcrip-
tion. In addition, the depletion of XNP/dATRX does
not affect DREF protein levels, suggesting that dATRX
does not regulate DREF gene expression (Supplementary
Figure S7).
On the other hand, the simultaneous overexpression of
XNP/dATRX and knockdown of DREF cause lethality
and the organisms die during the embryo development.
We also analyzed the effect in Drosophila of the simultan-
eous overexpression of both XNP/dATRX and DREF
using the pnr-GAL4 driver. Intriguingly, we also found
that this combination is lethal. Different possibilities
may explain these two results, since both XNP/dATRX
and DREF independently may regulate different set
of genes (as it is suggested polytene chromosomes
immunostainings, see ahead). Therefore it is possible
that in either of these two conditions creates a dramatic
de-regulation in gene expression during the ﬂy develop-
ment leading to organism lethality.
A recent publication (44) has shown that DREF
depletion in the notum and in other subdomains of the
wing disc reduces or eliminates bristles. This phenotype is
due in part to the inﬂuence of DREF on PCNA gene
expression and affects the endoreplication process of
bristle development, which results in a lack of bristles.
The reduction in the number and size of machrocheates
in UAS-DREFi/pnr-Gal4 ﬂies found in our study
(Supplementary Figure S6) may be related to a cell prolif-
eration defect independent of pnr. Nevertheless, the dis-
ruption of the thorax is only observed in UAS-DREFi/
pnr-Gal4 ﬂies (Figure 4, upper panel). Our genetic
analyses indicate that we can separate these two pheno-
types. We think that DREF depletion on the PCNA gene
regulatory sequences would lead to the bristle defects,
meanwhile depletion of this molecule on the pnr
regulatory sequences would lead to the notum defects.
XNP/dATRX represses transcription of some, but not all,
of the genes regulated by DREF
The genetic results suggest that XNP/dATRX negatively
regulates the expression of pnr, which requires DREF to
be properly expressed. Therefore, we studied the transcript
levels of other genes that are positively regulated
by DREF in conditions where XNP/dATRX levels were
altered. To perform this analysis, we used the Act5C-Gal4
driver to overexpress or reduce XNP/dATRX levels
ectopically. We measured the mRNA levels of E2F,
osa and PCNA from embryonic total RNA through
qRT–PCR. These three genes are positively regulated by
DREF. As a control, we used the p8/TTDA transcript
(31), which we found to be unaffected by XNP/dATRX.
We also analyzed the transcript of the ribosomal protein
rp49, which is generally used as a reference control to
measure mRNA levels in Drosophila. However, it should
be noted that genes encoding ribosomal proteins
in mammals have been reported to be regulated by
DREF (45).
In ﬂies that ectopically express XNP/dATRX, we
detected a reduction on the E2F and osa transcript levels
(Figure 5C and D). However, the transcript levels of
PCNA and rp49, which are also positively regulated by
DREF, were enhanced (Figure 5B and E) This result is
intriguing because E2F acts as an activator of PCNA tran-
scription. At the same time, it has also been reported that
E2F may act as a repressor of PCNA expression in some
Table 1. DREF and XNP/dATRX knockdowns modify pnr thorax
cleft and machrochaete defects
Relevant genotype Thoracic cleft
defects (%)
Macrocheate
(%)
+/+;UAS-DREFi/TM3 0 (0/177)
a 0 (0/177)
+/+; pnr-Gal4/MKRS 0 (0/160) 0 (0/160)
+/+; pnr-Gal4/UAS-DREFi 100 (86/86) 100 (86/86)
UAS-dATRXi/+; pnr-Gal4/
UAS-DREFi
0 (0/73)
b 65 (48/73)
aFlies with thoracic cleft and absence of macrochaetes from the total
number of ﬂies counted for each genotype.
bThe reduction of the thoracic cleft phenotype and the absence of
machrochaetes are shown in Figure 4A.
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mRNA levels may be indirect and not a direct con
sequence of XNP/dATRX ectopic expression. To deter-
mine whether dATRX is found at the PCNA-DRE
element in embryonic chromatin, we performed a ChIP
experiment using speciﬁc dATRX antibodies. We found
that dATRX is at the PCNA-DRE element (data not
shown), suggesting that dATRX may have a direct
impact on PCNA transcript levels; however, its interaction
with DREF in this region is not clear because Re-ChIP
experiments using DREF and dATRX antibodies pulled
down the PCNA-DRE only marginally (Figure 6).
Interestingly, in XNP/dATRX-depleted ﬂies, the E2F,
osa and PCNA transcript levels do not respond sig-
niﬁcantly to the reduction of XNP/dATRX dosage
(Figure 5). This result contrasts with the pnr
transcriptional deregulation that we have found as a con-
sequence of XNP/dATRX depletion (Figure 2C), suggest-
ing that pnr gene expression is particularly sensitive to
XNP/dATRX levels. We also found that rp49 transcript
levels are reduced under XNP/dATRX depletion, suggest-
ing that XNP/dATRX may be a positive factor for rp49
expression. Taken together, these data show that XNP/
dATRX can act as a repressor for some, but not all,
DREF regulated genes, such as pnr, and suggest that
XNP/dATRX exerts a promoter-speciﬁc effect on gene
expression.
XNP/dATRX regulates pnr gene expression by binding
DREF in chromatin
We have shown that both, DREF and XNP/dATRX are
pnr transcriptional regulators. Thus, we investigated
Figure 5. Effect on the mRNA levels of different genes regulated by DREF by the overexpression and depletion of XNP/dATRX. Total RNA from
ﬂies either overexpressing XNP/dATRX or an XNP/dATRX RNAi construct under the control of the Act5C-Gal4 driver (ectopic expression) or
without it, was puriﬁed from embryos and used in quantitative RT–PCR analysis for different gene transcripts. The genotypes are indicated for each
bar color. Black bars indicate the quantiﬁcation of the speciﬁc mRNA in ﬂies with only the Act5C-Gal4driver; gray bars indicate ﬂies expressing the
XNP/dATRX RNAi and white bars correspond to ﬂies overexpressing XNP/dATRX. As an internal control we used the mRNA levels of the Dmp8
transcript, which is not affected by the XNP/dATRX levels. The relative expression values are adjusted to 1, which correspond to Act5C-Gal4/CyO;
+/+ organisms. (A) Quantiﬁcation of mRNA levels of XNP/dATRX. Note that the levels of the speciﬁc mRNA is reduced when the RNAi against
XNP/dATRX is expressed (RNAi-dATRX/Act5C-Gal4) and increased by the overexpression of XNP/dATRX in the UAS-XNP/dATRX (UY3132 line).
(B–E) Quantiﬁcation of the mRNA levels of E2F; osa; PCNA; rp49 in ﬂies overexpressing XNP/dATRX or a RNAi against XNP/dATRX. In all cases
the analyzed RNA was prepared from three independent experiments and each cDNA preparation ampliﬁed three times for posterior qRT–PCR.
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occurred via a direct interaction with DREF or through
an independent mechanism. The fact that XNP/dATRX
genetically and physically interacts with DREF supports
the hypothesis that the repression of pnr by XNP/dATRX
occurs via a physical contact with DREF. Overexpression
of XNP/dATRX in the pnr expression domain enhanced
the thoracic cleft phenotype, as was observed during
DREF knockdown (Figures 2 and 4). In this situation,
XNP/dATRX may be sequestering DREF and preventing
it from interacting with DRE elements, thereby inhibiting
transcription.
ChIP assays of pnr chromatin from XNP/dATRX
overexpressing ﬂies, show that in spite of XNP/dATRX
increased levels, DREF still occupies the DRE-pnr
element, suggesting that XNP/dATRX did not prevent
the association of DREF with this DRE site
(Figure 6A). To determine whether XNP/dATRX inter-
acts with DREF at the DRE-pnr element, we performed
ChIP-western and Re-ChIP experiments. The DREF
antibody was used in a typical ChIP assay with
wild-type-embryo chromatin, and the precipitated
proteins were analyzed by western blot analysis to
identify DREF and XNP/dATRX. We found that both
Figure 6. A XNP/dATRX–DREF complex binds the DRE-pnr element. (A) DREF-ChIP assay from embryos overexpressing XNP/dATRX using
an Act5C-Gal4 driver. Note that even when XNP/dATRX overexpression reduces pnr mRNA levels (Figure 2), DREF is still located at the pnr- and
pnr--DRE elements. The ChIP experiment was performed by triplicate (P=0.001). (B) ChIP-western assay. ChIP was performed with the
anti-DREF antibody and the precipitated chromatin analyzed in a typical western blot to search for the presence of DREF and dATRX. Note
that both proteins can be detected. (C) Re-ChIP experiment using the DREF antibody for the ﬁrst ChIP and then the XNP/dATRX antibody for the
Re-ChIP. An unrelated antibody was used as negative control for the ﬁrst ChIP and then immunoprecipitated with the dATRX antibody (white bars,
MOCK). The Re-ChIP shows the average of three independent experiments (P=0.01). (D) Polytene chromosomes prepared from wild-type larvae
were simultaneously stained with the anti-DREF (green signal) and anti-XNP/dATRX antibodies (red signal). Several merge bands containing both
factors can be visualized (yellow arrows), regions where only XNP/dATRX is present (red arrows) and regions where only DREF is present (green
arrows). (E) ChIP experiments using the DREF and XNP/dATRX antibodies in wild-type and DREFi knocked-down embryos. The genotype of the
organisms tested is Act5C-Gal4/+; UAS-DREFi/+. OreR corresponds to immunoprecipitated chromatin from wild-type organism (gray bars). DREFi
corresponds to immunoprecipitated chromatin from embryos expressing the anti DREF RNAi (black bars). Mock is the incubation with unrelated
antibody (white bars). Antibodies used for each IP are indicated at the bottom of the ﬁgure. (F) Model on the role of DREF and XNP/dATRX in
the transcriptional regulation of pnr-. Among other factors that regulate pnr gene expression during development, the interaction between DREF
and dATRX may participate in the establishment of an active or negative effect in gene regulation.
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precipitated chromatin by the speciﬁc antibodies
(Figure 6B), indicating that XNP/dATRX can be
co-localized together with DREF in the chromatin. In
Re-Chip assays, in which we ﬁrst precipitated the chroma-
tin with the DREF antibody and then with the XNP/
dATRX antibody and then quantiﬁed the precipitated
DRE-pnr element region by qPCR, we found that both
XNP/dATRX and DREF are bound to this element
in vivo (Figure 6C). Interestingly, in this Re-Chip assay,
there was no XNP/dATRX enrichment at the
DRE-PCNA element, contrary to the XNP/dATRX
enrichment found at the DRE-pnr- element, suggesting
that the XNP/dATRX transcriptional effect on PCNA
(Figure 5), may be an indirect effect. It is important to
note that Re-ChIP does not necessarily mean that XNP/
dATRX is binding through DREF. The chromatin in
these experiments is fragmented to 200- to 800-bp range,
and therefore it is equally possible that XNP/dATRX is
binding at neighboring DREF sites and is brought down
by intervening DNA. However, the depletion of DREF
reduces the occupancy of XNP/dATRX at the pnr DRE
sites (see ahead).
To support the idea that DREF and XNP/dATRX
can be located at the same chromosomal positions, we
performed co-immunostaining experiments in polytene
chromosomes to identify DREF and XNP/dATRX
location sites. XNP/dATRX and DREF co-localize in
around half of the sites (Figure 6D). In fact, we even
observed co-localization of XNP/dATRX and DREF in
the so-called pericentric focus (Figure 6D, white arrow,
18). However, some regions showed no co-localization
of the two factors (Figure 6D), suggesting a highly
dynamic behavior of both factors in the chromatin and
that XNP/dATRX may interact with other factors besides
DREF to bind speciﬁc chromatin regions (see below).
As previously mentioned, XNP/dATRX lacks the ADD
motif. Therefore, we hypothesized that XNP/dATRX
requires an interaction with other factors like DREF
to bind to speciﬁc regions of the chromatin. Thus, we
depleted DREF using RNAi and the Act5C-Gal4 driver
in embryos and performed ChIP assays to determine the
occupancy of DREF and ATRX in the DRE-pnr elements.
We found that when DREF was depleted, the occupancy
of both dATRX and DREF in the DRE-pnr elements was
reduced (Figure 6E). This result indicates that dATRX
requires the presence of DREF to bind to the chromatin
at the DRE element in the pnr- promoter.
DISCUSSION
XNP/dATRX interacts physically with DREF to regulate
pnr gene expression
In Drosophila, little is known about the genes regulated by
XNP/dATRX and how it is recruited to chromatin sites.
In this work, we demonstrated that XNP/dATRX inter-
acts with the trans-activation domain of the transcription
factor DREF and that this interaction mediates XNP/
dATRX recruitment to chromatin at the pnr promoter.
Furthermore, depletion of DREF signiﬁcantly reduces
the occupancy of dATRX in these chromatin regions
and suggests that XNP/dATRX occupancy at the DRE
sites depends on the presence of DREF. This observation
also suggests that the interaction between the two proteins
at the pnr- promoter results in the repression of pnr
transcription.
Mammalian ATRX has two important domains: the
helicase/ATPase SNF2 domain and the ADD domain.
As mentioned before, only three proteins share the ADD
domain: ATRX, DNMT3a and DNMT3L. The ADD
domain of the DNMTs and hATRX are able to bind
to histone tails, thus providing a model for how these
proteins bind to chromatin (5–7). XNP/dATRX, as well
as its counterpart in Caenorhabditis elegans, lacks the
ADD domain present in the mammalian protein.
Several studies have shown that XNP/dATRX is a
chromatin-associated protein (17–19), but there is no
evidence of direct binding to DNA sequences or to
histones. For this reason, the identiﬁcation of target
sequences or promoters of XNP/dATRX has been
elusive. We hypothesized that XNP/dATRX requires an
interaction with other proteins to reach its target sites/
promoters and to achieve its functions in chromatin.
We found that one of these factors is DREF. DREF is a
transcriptional activator that was initially found to
regulate the expression of several genes required for
DNA replication and cell proliferation (47,48). Recently,
it has been demonstrated that DREF also activates the
expression of many other genes in Drosophila and in
human cells and that putative DRE motifs are present at
many promoter regions in the ﬂy genome (20).
The region of DREF that interacted with the amino
terminus of XNP/dATRX corresponded to the transacti-
vation domain of the protein (CR3 region). XNP/
dATRXL bound to HP1a through a motif that covers
amino acids 245–249 (17). Therefore, the DREF inter-
action with XNP/dATRX did not overlap with the
HP1a interaction site. Moreover, it is important to
mention that this interaction only occurs between DREF
and the long isoform of XNP/dATRX because the short
isoform does not contain this region. Further experiments
with both isoforms of XNP/dATRX will be necessary to
address the biological importance of both isoforms. CoIP
experiments also conﬁrmed the association between the
two proteins, suggesting that this interaction took place
in vivo in the cell nucleus (Figure 1C). Additionally,
immunoﬂuorescence analysis of polytene chromosomes
indicated that both proteins co-localized at several, but
not all, chromatin regions, suggesting that there may be
other factors in addition to DREF that mediate XNP/
dATRX recruitment to chromatin (Figure 6D). In fact,
we identiﬁed several putative candidates using our
two-hybrid screen (Supplementary Table S1).
It was initially reported that the longer isoform of XNP/
dATRX is preferentially located in the chromocenter and
less abundantly in other chromosomal regions (17). The
short isoform apparently has a different distribution and
is located in many regions on polytene chromosomes. In
addition, it has recently been reported that XNP/dATRX
is required for HP1a deposition in pericentric
b-heterochromatin of the X chromosome (19). However,
Nucleic Acids Research,2012, Vol.40, No. 4 1471a second recent report challenged those results (18)
because the authors found that XNP/dATRX is preferen-
tially found in euchromatic regions. Furthermore, XNP/
dATRX seems to co-localize with the H3.3 histone variant
(which is a histone enriched in euchromatic regions) in
polytene chromosomes (18). Moreover, it has recently
been shown that hATRX interacts with the H3.3 histone
in embryonic stem cell telomeres, and together with
DAXX, it is important for the incorporation of H3.3 at
the telomeres (49,50). Our experiments provide further
support for the euchromatic localization of XNP/
dATRX. Thus, it could be possible that XNP/dATRX
represses the expression of genes located in euchromatin.
However, a positive impact on gene expression cannot be
discarded, and it would be interesting if XNP/dATRX
also interacts with the H3.3 histone at the DRE sites.
Nevertheless, our results in Drosophila suggest that
DREF is one of the factors that interacts with XNP/
dATRX to regulate gene expression and that it localizes
to euchromatic regions.
The DREF-XNP/dATRX interaction has a functional
relevance in the regulation of pnr
A previous report from another group (39) is in accord-
ance with our own data which demonstrate that the
ectopic expression of dATRX in the pnr expression
domain enhances pnr loss-of-function phenotypes, sug-
gesting that XNP/dATRX may act as a pnr negative
transcriptional regulator. Speciﬁcally, reduction of the
two XNP/dATRX isoforms with RNAi suppressed
mutant phenotypes caused by different pnr alleles. This
repressive role of XNP/dATRX in pnr expression is also
supported by the fact that ectopic expression of XNP/
dATRX in the embryo causes a reduction in the mRNA
levels of the pnr isoforms and that the XNP/dATRX
depletion by RNAi increases the pnr transcripts level.
However, the DREF knockdown in the pnr-Gal4 expres-
sion domain enhances thoracic cleft defects caused by a
reduction in pnr- levels, and these defects are suppressed
by the simultaneous XNP/dATRX knockdown. Thus,
these factors interact genetically, and they have antagon-
istic roles in pnr regulation. Moreover, we also found
that DREF can bind to the DRE element that is located
in the pnr- control region. Based on these results, we
suggest that DREF activates pnr- gene expression
because its depletion enhances the loss of function pheno-
types found in pnr-Gal4 ﬂies. XNP/dATRX is targeted to
the DRE element at the pnr- promoter through its direct
interaction with DREF and this interaction negatively
regulates pnr (Figure 6F). However, this model opens
the question of why XNP/dATRX depletion restores
the pnr- transcript levels in DREF-depleted thoraxes
(Figure 4B) given the assumption that lowering DREF
dosages would reduce consequently the amount of XNP/
dATRX at the DRE regulatory sequence. A possible
explanation is that the DRE element controlling pnr- is
very sensitive to changes in the DREF-XNP/dATRX ratio
(Figure 4B). We also think that other factors binding to
the regulatory regions of pnr, may inﬂuence DREF and
XNP/dATRX location at the DRE and moreover DREF
and/or XNP/dATRX, could be regulating the expression
of upstream genes, therefore indirectly inﬂuencing pnr
gene expression.
Interestingly, it has been reported that DREF associates
with TRF2 and can recognize the PCNA core promoter
(24). Therefore, it is possible that DREF may act as a
co-activator that is necessary for the expression of genes
required for cell proliferation, which are also regulated by
TRF2. The DRE element, we identiﬁed at the pnr-
promoter overlaps with an identiﬁed sequence that is
occupied by TRF2 (51). These data and our molecular
and genetic assays suggest that DREF likely activates
pnr- expression through its interaction with TRF2.
Therefore, it is possible that the mechanism of pnr gene
inactivation by XNP/dATRX occurs via the interference
of the interaction between DREF and TRF2.
XNP/dATRX has a possible dual role in transcriptional
regulation
In this work, we present data indicating that in addition to
pnr, the ectopic expression of XNP/dATRX also represses
E2F and osa transcription. However, this was not true for
other genes, such as PCNA, which requires DREF for its
expression. In fact, in some examples, we found an
increase in the level of speciﬁc mRNAs when XNP/
dATRX was overexpressed. Contrary to the results
observed with pnr, XNP/dATRX depletion did not
affect the mRNA levels of PCNA, E2F and osa;
however, rp49 mRNA levels were decreased in this
condition (Figure 5). These results suggest that there is a
selective effect of dATRX in gene regulation and that
XNP/dATRX may be required for both gene activation
and gene repression. A recent microarray analysis
of a mouse model that lacks ATRX in the forebrain
identiﬁed several overexpressed genes, as well as some
genes that were downregulated. The functions of both
sets of genes were diverse, but these results suggest that
in mice, ATRX is required for gene activation and repres-
sion (15,16). In addition, the forebrain transcript analysis
in the ATRX mutant mice indicated that ATRX is not a
global regulator of gene expression, as it seems that
ATRX acts through other factors like MeCP2, cohesin
and CTCF in the regulation of imprinted genes in the
postnatal mouse brain (15,16). A global analysis of
changes in transcript levels caused by the XNP/dATRX
overexpression and depletion in Drosophila will be
required to achieve a comprehensive view of the inﬂuence
of XNP/dATRX on gene regulation.
Pnr belongs to the GATA family of transcription
factors, which has been conserved over the course of evo-
lution. For example, there are six GATA family members
in mammals. Therefore, it is important to assess whether
ATRX regulates some of these factors in vertebrates.
This is of particular interest because some patients
afﬂicted with ATRX syndrome suffer from a-thalassemia,
and it is known that the GATA 1 and GATA 2 factors are
involved in the regulation of the globin genes (52).
Moreover, it has recently been reported that human
ATRX is recruited to G-rich tandem repeat sequences
that have the potential to form G-quadruples, and these
1472 Nucleic Acids Research, 2012,Vol.40, No. 4may have a negative impact on genes in the vicinity, such
as the a-globin genes (10). It will be interesting in future
studies to determine if XNP/dATRX is also recruited to
G-rich sequences.
In conclusion, our results show that DREF is required
for the proper expression of pnr and that XNP/dATRX
binds to DREF at the DRE sites, resulting in the repres-
sion of pnr gene expression. This establishes a connection
between a chromatin remodeling factor (XNP/dATRX)
and a transcriptional activator (DREF) in the regulation
of an important gene (pnr). In addition, these studies in
Drosophila open new avenues for the study of human
pathologies generated by mutations in hATRX. For
example, human cells code for a DREF homolog, and
as hATRX interacts with multiple factors to achieve its
functions, it will be important to determine if hATRX
functionally interacts with DREF in humans. These
types of studies will allow us to assess whether genes
regulated by DREF are affected in cells derived from
patients afﬂicted with the ATRX syndrome.
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